Celera Genomics Group-an Applera Corp. Business Grants Real Time PCR License to Siemens Medical Solutions Diagnostics (Berkeley, CA)
Published: Oct 01, 2007
ROCKVILLE, Md. & ALAMEDA, Calif.--(BUSINESS WIRE)--Celera (NYSE:CRA), an Applera Corporation business, announced today that it has entered into agreements with Siemens Medical Solutions Diagnostics which include a license conferring rights in the human in vitro diagnostics field to the Applera patents for real time PCR thermalcycling instruments and reagents. The financial details of these agreements were not disclosed.